Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Poland transposes EU Braille format requirements for drug packaging

This article was originally published in RAJ Devices

Executive Summary

As of 1 November 2008, marketing authorisation holders in Poland will be required to use the Braille format on human drugs packaging. The Polish ministry of health has already started a consultation process on the draft decree introducing the change, which is a result of amendments made in the EU pharmaceutical legislation in 2004. Recently, the ministry also issued a separate decree concerning the labeling of veterinary medicines. To date, packaging requirements for human and veterinary drugs have been regulated in one decree, which was adopted in 2002.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC092897

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel